Page 151 - Atti_SNO_LX_2021.qxd
P. 151

Proceedings SNO                                                    “LX Congresso Nazionale SNO”














































                litis: Updates on an inflammatory CNS syndro-  Figura 1. Sequenze T2 e STIR del
                me. Neurology 2016; 87 (9 Suppl 2): S38-45.
                                                      midollo spinale: lesioni confluenti si
              3. Cao L, Ren L. Acute disseminated encepha-  estendono da D10 fino al cono mi-
                lomyelitis after severe acute respiratory syn-  dollare. Sequenze FLAIR dell’ence-
                drome coronavirus 2 vaccination: a case re-  falo: diverse lesioni bilaterali e a-
                port. Acta Neurol Belg 2021: 1-3.     simmetriche, a margini poco defini-
                                                      ti, interessano la sostanza bianca, i
              4. Voysey M, Clemens SAC, Madhi SA, Weckx
                                                      gangli della base e la corteccia; una
                LY, Folegatti PM, Aley PK, Angus B, Baillie  lesione ad aspetto tumefattivo è vi-
                VL, Barnabas SL, Bhorat QE, Bibi S, Briner C,  sibile a livello del lobo frontale di si-
                Cicconi P, Collins AM, Colin-Jones R, Cutland  nistra; le lesioni non presentano en-
                CL, Darton TC, Dheda K, Duncan CJA, Emary  hancement contrastrografico nelle
                KRW, Ewer KJ, Fairlie L, Faust SN, Feng S,  sequenze T1 con gadolinio.
                Ferreira DM, Finn A, Goodman AL, Green CM,
                Green CA, Heath PT, Hill C, Hill H, Hirsch I,
                Hodgson SHC, Izu A, Jackson S, Jenkin D, Joe
                CCD, Kerridge S, Koen A, Kwatra G, Lazarus
                R, Lawrie AM, Lelliott A, Libri V, Lillie PJ, Mallory R, Mendes
                AVA, Milan EP, Minassian  AM, McGregor  A, Morrison H,
                Mujadidi YF, Nana A, O’Reilly PJ, Padayachee SD, Pittella A,  5. Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-
                Plested E, Pollock KM, Ramasamy MN, Rhead S, Schwarzbold  Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck
                AV, Singh N, Smith A, Song R, Snape MD, Sprinz E, Sutherland  EA, Dold C, Faust SN, Finn A, Flaxman AL, Hallis B, Heath P,
                RK, Tarrant R, Thomson EC, Török ME, Toshner M, Turner DPJ,  Jenkin D, Lazarus R, Makinson R, Minassian AM, Pollock KM,
                Vekemans J, Villafana TL, Watson MEE, Williams CJ, Douglas  Ramasamy M, Robinson H, Snape M, Tarrant R, Voysey M,
                AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID  Green C, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard
                Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-  AJ; Oxford COVID Vaccine Trial Group. Safety and immuno-
                19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis  genicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-
                of four randomised controlled trials in Brazil, South Africa, and  2: a preliminary report of a phase 1/2, single-blind, randomised
                the UK. Lancet 2021; 397 (10269): 99-111.        controlled trial. Lancet 2020; 396 (10249): 467-478.



                                                          - 149 -
   146   147   148   149   150   151   152   153   154   155   156